Study S001695

A Study of Cardiovascular Events iN Diabetes Plus

Name: LivingGLP1 adjudicated trial data and network meta-analysis results
Creator: Ahmad Sofi-Mahmudi
License: https://creativecommons.org/licenses/by/4.0/

ClinicalTrials.gov record

Registration

Registration: NCT05441267
Acronym: ASCEND PLUS
Study type: INTERVENTIONAL
Allocation: RANDOMIZED
Phase: PHASE4
Masking: QUADRUPLE
Status: ACTIVE_NOT_RECRUITING
Enrollment: 21296
Start: 2023-03-13
Primary completion: 2028-08-17
Lead sponsor: University of Oxford
Conditions: Diabetes Mellitus, Type 2
Interventions: DRUG:Semaglutide Oral Tablet; DRUG:Placebo oral tablet
Results posted: FALSE
Individual participant data sharing: YES

Registered primary outcomes

Time to the first occurrence of a Major Adverse Cardiovascular Events (MACE+) [Scheduled treatment period (anticipated median follow-up period of 5-years)]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.